Where does Carlos Solórzano work?

Carlos Solórzano is Principal at Ally Bridge Group.

What check size does Carlos Solórzano write?

Carlos Solórzano typically writes checks of $10K – $50K.

Where did Carlos Solórzano go to school?

Carlos Solórzano studied at UC Irvine (Ph.D., Pharmacology and Toxicology); Keck Graduate Institute (Intensive Summer Business Course); California State Polytechnic University-Pomona (B.Sc., Chemical Engineering).

Carlos Solórzano

Investor

Principal at Ally Bridge Group

San Francisco Bay Area

Writes $10K – $50K checks · typically $25K

Find your path to Carlos

496 people in our graph share verified history with Carlos — schools, employers, funds. One of them is your warm intro.

Francisco GimenezunlockedCarlos: together at University of California, San Francisco (2010)

×2Carlos: together at Deutsche Bank

×3Carlos: together at Oppenheimer & Co. Inc.

Carlos: together at Keck Graduate Institute

Experience

Ally Bridge GroupPrincipalcurrent2024 — present
Ally Bridge GroupInvestor in residence2024San Francisco Bay Area
Section 32Sr. Principal2022 — 2024San Francisco Bay Area
Pivotal Life SciencesSr. Associate2019 — 2022San Francisco Bay Area
Ultragenyx Pharmaceutical Inc.Assoc Director, Corporate Strategy2018 — 2019
Deutsche BankEquity Research Associate - Biotechnology2016 — 2018San Francisco, CA
Oppenheimer & Co. Inc.Equity Research Associate - Biotechnology2015 — 2016San Francisco, CA
University of California, San FranciscoNIH Postdoctoral Fellow2010 — 2015San Francisco Bay Area
Oxbridge Biotech RoundtablePresident - Bay Area Chapter2014San Francisco Bay Area

Skills & more

Molecular BiologyPharmacologyBiochemistryCell BiologyNeuroscienceCell CultureAnimal ModelsDrug DiscoveryToxicologyConfocal MicroscopyLaboratoryIn Vivo

+7 more

ImmunohistochemistryEnzyme KineticsInflammationFluorescence MicroscopyIn VitroPainAnalytical Chemistry

Languages French · Spanish

Series 7, 63, 86, 87

From Carlos's professional profile.

Colleagues at Ally Bridge Group

Andrew Lam

Managing Director, Head of Biotech Private Equity at Ally Bridge Group

Frank Yu

Investor at Ally Bridge Group

Kevin Reilly

Managing Director and Head of MedTech Investments at Ally Bridge Group

Megan MacDonagh

Senior Associate at SV Health Investors

Slanix Paul Alex

President and Portfolio Manager, Public Equity at Ally Bridge Group

Steven Plachtyna

Investor at Ally Bridge Group

Network4

Ainhoa Maiz

Principal at S32

Andy Harrison

General Partner, CEO at S32

Bill Maris

General Partner, Founder at S32

Mike Pellini

General Partner at S32

Investors connected to Carlos in public investor directories — a warm-intro map.

Frequently asked questions

Who is Carlos Solórzano?: Principal at S32
Where does Carlos Solórzano work?: Carlos Solórzano is Principal at Ally Bridge Group.
What check size does Carlos Solórzano write?: Carlos Solórzano typically writes checks of $10K – $50K.
Where did Carlos Solórzano go to school?: Carlos Solórzano studied at UC Irvine (Ph.D., Pharmacology and Toxicology); Keck Graduate Institute (Intensive Summer Business Course); California State Polytechnic University-Pomona (B.Sc., Chemical Engineering).

Same school

Also attended UC Irvine205

Christian BuergerPortfolio Development at Intel Capital Jonathan GiegCommunity Manager at Pantera Capital Ryan LaurinManaging Director at Marlin Equity Partners Christopher WestSenior Legal Counsel at Qualcomm Ventures Pascal KroteePrincipal, Ph.D. at RiverVest Venture Partners Zack IsaacsonVenture Partner at Rackhouse Venture Management Lp

+ 199 more

Also attended Keck Graduate Institute8

Seth LieblichInvestment Team at 8VC Mira ChaurushiyaManaging Director at Westlake Village BioPartners Kavya TallapakaConsulting at Rock Health Adar Makovski SilversteinPrincipal at Arkin Capital Curt HerbertsInvestor at Premji Invest Eric TanManaging Partner at Blackwood Healthcare Breakthroughs

+ 2 more

Also attended California State Polytechnic University-Pomona24

Neha KumarVenture Partner at Floating Point Kevin CovertCo-Founder & Managing Director at BTECH CONSORTIUM Nicole KinseyVP Content, Partner at StartUp Health Joseph F. LovettManaging Director at Louisiana Funds Joan LeeDirector of Finance at Shamrock Capital Mary KamariCorporate Affairs & Investor Relations Executive at Trade and Development Bank

+ 18 more

Shared employers

Also worked at Section 3216

Andy HarrisonGeneral Partner, CEO at S32 Mike PelliniGeneral Partner at S32 Alice CheungPartner, Talent at S32 Bayan AlizadehPartner at S32 Derrick ChowPartner at S32 Wesley TilluPartner at S32 focused on frontier technology investments

+ 10 more

Also worked at Pivotal Life Sciences11

AJ Velasquez-MaoAssociate at Dolby Family Ventures Glenn BatchelderVenture Partner at Pivotal Life Sciences Peter BisgaardManaging Director at Pivotal Life Sciences Rob HopfnerManaging Director at Pivotal Life Sciences Jeni LeePartner at Pivotal Life Sciences Benjamin LiVice President at Pivotal Life Sciences

+ 5 more

Also worked at Ultragenyx Pharmaceutical Inc.7

Juan CuevaDirector, Early Innovation Partnering at Johnson & Johnson at Joyance Partners Christina BroomesCommercial Advisor at 2Flo Ventures Marten SteenManaging Partner at HealthCap Linda TsangExecutive Assistant at Venrock Cory BystromSenior Director, Biomarker & Analytical Development at AOA Dx Yael WeissExecutive Officer, Director at Mahzi Therapeutics

+ 1 more

Also worked at Deutsche Bank880

Bill GurleyGeneral Partner Emeritus at Benchmark Vlad YatsenkoCo-founder & CTO of Revolut Funmi GarrickFinance and Operations at Impact America Fund Giuseppe IademarcoHead of Global Partnership at P101 Ventures Jeppe ZinkPartner at Northzone Dan MoreheadFounder & CEO at Pantera Capital

+ 874 more